MUC Research GmbH   Report issue

For profit Phase 1
Founded: Munich Germany (2011)

Organization Overview

First Clinical Trial
2014
NCT02203461
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Insulin Resistance (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 7